Capital International Investors Vertex Pharmaceuticals Inc Transaction History

Capital International Investors

$557 Billion
Q2 2025

A detailed history of Capital International Investors transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Capital International Investors holds 2,635,903 shares of VRTX stock, worth $1.02 Billion. This represents 0.21% of its overall portfolio holdings.

Number of Shares

2,635,903

Previous 649,899 305.59%

Holding current value

$1.02 Billion

Previous $315 Million 272.44%

% of portfolio

0.21%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$421.16 - $509.5 $836 Million - $1.01 Billion	1,986,004 Added 305.59%	2,635,903 $1.17 Billion
Q1 2025 May 12, 2025	BUY	$402.49 - $513.76 $124 Million - $158 Million	307,387 Added 89.74%	649,899 $315 Million
Q4 2024 Feb 13, 2025	BUY	$396.64 - $516.74 $136 Million - $177 Million	342,512 New	342,512 $138 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $29.5 Million - $36.7 Million	-125,595 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $421 Million - $496 Million	-1,901,637 Reduced 93.8%	125,595 $32.8 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $340 Million - $430 Million	-1,922,320 Reduced 48.67%	2,027,232 $445 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $109 Million - $122 Million	-599,451 Reduced 13.18%	3,949,552 $716 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $280 Million - $330 Million	-1,493,566 Reduced 24.72%	4,549,003 $917 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $133 Million - $155 Million	-642,853 Reduced 9.62%	6,042,569 $1.3 Billion
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $248 Million - $331 Million	1,199,338 Added 21.86%	6,685,422 $1.58 Billion
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $66.8 Million - $79.2 Million	-261,425 Reduced 4.55%	5,486,084 $1.49 Billion
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $179 Million - $235 Million	-795,089 Reduced 12.15%	5,747,509 $1.67 Billion
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $55.5 Million - $68.8 Million	277,804 Added 4.43%	6,542,598 $1.56 Billion
Q4 2019 Feb 18, 2020	BUY	$166.71 - $223.91 $540 Million - $726 Million	3,241,404 Added 107.21%	6,264,794 $1.37 Billion
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $20,446 - $23,012	123 Added 0.0%	3,023,390 $512 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $11 Million - $12.7 Million	-66,904 Reduced 2.17%	3,023,267 $554 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $64.3 Million - $76.4 Million	392,648 Added 14.56%	3,090,171 $568 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $26.5 Million - $33.5 Million	-174,400 Reduced 6.07%	2,697,523 $447 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $482 Million - $554 Million	2,871,923 New	2,871,923 $554 Million

Others Institutions Holding VRTX

# of Institutions

1,810

Shares Held

239M

Call Options Held

1.95M

Put Options Held

1.12M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $99.5B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account

Capital International Investors Vertex Pharmaceuticals Inc Transaction History